Cilamac 250 mg/250 mg Injection
₹861.93*
MRP ₹957.7
10% off
₹813.7*
MRP ₹957.7
15% CB
₹144 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Cilamac 250 mg/250 mg Injection is used to treat severe bacterial infections of the lungs, heart, bladder, skin, kidneys, bones, joints, blood, stomach and female reproductive organs. Cilamac 250 mg/250 mg Injection may also be used in the management of patients with low white blood cell count who have a fever, which is suspected to be due to bacterial infection. Bacterial infections are caused due to the multiplication of harmful bacteria inside or on the body. Cilamac 250 mg/250 mg Injection does not work against infections caused by the virus, including cold and flu.
Cilamac 250 mg/250 mg Injection is a combination of two drugs, namely: Cilastatin (dehydropeptidase inhibitor) and Imipenem (antibacterial). Cilastatin inhibits the dehydropeptidase enzyme, which causes the breakdown of Imipenem, thereby helps imipenem to stay active for a longer duration. Imipenem prevents the formation of the bacterial protective covering, which is necessary for the survival of the bacteria. Together, Cilamac 250 mg/250 mg Injection helps to treat bacterial infections.
Cilamac 250 mg/250 mg Injection will be administered by a healthcare professional; do not self-administer. In some cases, Cilamac 250 mg/250 mg Injection may cause common side effects such as nausea, vomiting, diarrhoea, swelling, and redness at the site of injection. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Consult your doctor if you are pregnant or breastfeeding. Cilamac 250 mg/250 mg Injection may cause dizziness, so drive with caution. Avoid alcohol consumption as it might cause increased dizziness and sleepiness. Cilamac 250 mg/250 mg Injection should not be given to children below one year or those who weigh below 30kg with kidney problems. Cilamac 250 mg/250 mg Injection is not recommended in paediatric patients with CNS infections due to the risk of seizures. Keep your doctor informed about your health condition and medications to rule out any unpleasant side effects.
Cilamac 250 mg/250 mg Injection is a combination of two drugs, namely: Cilastatin (dehydropeptidase inhibitor) and Imipenem (antibacterial). Cilamac 250 mg/250 mg Injection is used to treat severe bacterial infections of the lungs, heart, bladder, skin, kidneys, bones, joints, blood, stomach, and female reproductive organs. Cilamac 250 mg/250 mg Injection may also be used in the management of patients with low white blood cell count who have a fever, which is suspected to be due to bacterial infection. Cilastatin inhibits the dehydropeptidase enzyme, which causes the breakdown of Imipenem, thereby helps imipenem to stay active for a longer duration. Imipenem prevents the formation of the bacterial protective covering, which is necessary for the survival of the bacteria. Together, Cilamac 250 mg/250 mg Injection helps to treat bacterial infections. Imipenem is a broad-spectrum antibiotic that is effective against a wide range of aerobic and anaerobic bacteria.
Do not take Cilamac 250 mg/250 mg Injection if you are allergic to any of its components. Inform your doctor if you have an allergy to antibiotics, colitis, gastrointestinal disease, urinary/kidney problems, CNS disorders, seizures/fits, or liver problems. Consult your doctor if you are pregnant or breastfeeding. Avoid alcohol consumption as it might cause increased dizziness and sleepiness. Cilamac 250 mg/250 mg Injection should not be given to children below one year or those who weigh below 30kg with kidney problems. Cilamac 250 mg/250 mg Injection is not recommended in paediatric patients with CNS infections due to the risk of seizures. Cilamac 250 mg/250 mg Injection may cause dizziness and sleepiness, so drive with caution.
Drug-Drug Interactions: Cilamac 250 mg/250 mg Injection may interact with anti-viral (Ganciclovir), uricosurics (Probenecid), anti-epileptic (Valproic acid, Divalproex sodium), blood thinner (warfarin).
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interactions: Inform your doctor if you have colitis (inflammation in the lining of the colon), CNS disorders, hemodialysis, kidney or liver dysfunction.
Bacterial infections: A bacterial infection is a condition in which harmful bacteria enter, multiply, and infect the body. Harmful bacteria produce chemicals known as toxins, which can damage tissue and cause sickness. Symptoms of bacterial infection include fever, chills, and fatigue. Anyone can become infected with a bacterial infection. But, people with a weak immune system or taking immunosuppressive medicines are more prone to bacterial infection.
Alcohol
Caution
Avoid alcohol consumption as it might cause increased dizziness and sleepiness.
Pregnancy
Caution
Please consult your doctor if you are pregnant or planning for pregnancy. Your doctor will prescribe Cilamac 250 mg/250 mg Injection only if the benefits outweigh the risks.
Breast Feeding
Caution
Cilamac 250 mg/250 mg Injection may pass into breast milk. Please consult your doctor if you are breastfeeding; your doctor will decide if Cilamac 250 mg/250 mg Injection can be given to breastfeeding mothers or not.
Driving
Caution
Cilamac 250 mg/250 mg Injection may cause dizziness and sleepiness. Avoid driving or operating machinery unless you are alert.
Liver
Caution
Dose adjustment may be needed. Please consult your doctor if you have liver impairment/liver disease.
Kidney
Caution
Dose adjustment may be needed. Please consult your doctor if you have any concerns regarding this or if you have kidney impairment/kidney disease.
Children
Caution
Cilamac 250 mg/250 mg Injection should not be given to children below one year or those who weigh below 30kg with kidney problems. Cilamac 250 mg/250 mg Injection is not recommended in paediatric patients with CNS infections due to the risk of seizures.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes